Innovative CRISPR Delivery System Enhances Gene Editing in Human Myeloid Cells
A new virus-like particle (VLP)-based toolkit has been developed to facilitate efficient CRISPR editing in primary human myeloid cells, paving the way for advanced immunotherapy applications.
